Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.025 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |